2010. A Comparative Study of The Effect of Selectivity of COX-2 Inhibition (Meloxicam & Celecoxib) on Some Cardiovascular RiskMarkers in Patients With Rheumatoid Arthritis. Al Mustansiriyah Journal of Pharmaceutical Sciences. 7, 1 (Jun. 2010), 90–105. DOI:https://doi.org/10.32947/ajps.v7i1.321.